A detailed history of Spire Wealth Management transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 161,776 shares of VAXX stock, worth $1,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,776
Previous 8,969 1703.72%
Holding current value
$1,617
Previous $6,000 566.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$0.05 - $0.71 $7,640 - $108,492
152,807 Added 1703.72%
161,776 $40,000
Q1 2024

Apr 24, 2024

SELL
$0.62 - $0.86 $6,191 - $8,587
-9,986 Reduced 52.68%
8,969 $6,000
Q4 2023

Feb 06, 2024

BUY
$0.7 - $1.31 $13,268 - $24,831
18,955 New
18,955 $16,000
Q1 2023

May 09, 2023

BUY
$1.43 - $4.24 $2,145 - $6,360
1,500 New
1,500 $3,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $1.12M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.